news
GSK’s Emma Walmsley to step down as CEO
In a surprise announcement, she will be replaced at the…
In a surprise announcement, she will be replaced at the UK pharma company by its Chief Commercial Officer Luke Miels.
List view / Grid view
Emma Walmsley
news
GSK outlines $30bn, five-year plan for R&D and manufacturing in the US
The company’s investment strategy will also encompass AI, digital technology…
The company’s investment strategy will also encompass AI, digital technology and supply chain infrastructure.
news
GSK pledges £45m to support global AMR prevention
The CEO of GSK shared that the company is “proud…
The CEO of GSK shared that the company is “proud to be a founding partner, and hope others will join us to support this urgent priority” in tackling AMR.
news
GSK propels its progress to Net Zero
The lower carbon propellant has the potential to reduce greenhouse…
The lower carbon propellant has the potential to reduce greenhouse gas emissions from Ventolin (salbutamol) inhaler by approximately 90 percent, GSK reports.
news
GSK to open new global headquarters
GSK’s new global headquarters are expected to open in 2024,…
GSK’s new global headquarters are expected to open in 2024, allowing the company to be near London's global life sciences hub.
news
GSK narrowly averts strike action by upping workers’ pay
Trade union body Unite the Union reports that it has…
Trade union body Unite the Union reports that it has successfully secured an additional pay increase for GSK workers after an historic dispute threatened strike action.
![The GlaxoSmithKline headquarters building in Brentford, west London, June 2018 [Credit: Willy Barton / Shutterstock.com].](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/GSK-3-300x278.jpg)
![The GlaxoSmithKline headquarters building in Brentford, west London, June 2018 [Credit: Willy Barton / Shutterstock.com].](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/GSK-3-e1624534468322.jpg)
news
Tony Wood to replace Dr Hal Barron as GSK’s CSO
Tony Wood will assume accountability for R&D across GSK’s portfolio…
Tony Wood will assume accountability for R&D across GSK’s portfolio and pipeline from Dr Hal Barron on 1 August 2022.
news
GSK invests £50 million in renewable energy for Climate Week NYC
GSK announced multi-million renewable energy investment and low carbon inhaler…
GSK announced multi-million renewable energy investment and low carbon inhaler programme in run-up to New York Climate Week.
news
GSK reports £8.1 billion in Q2 sales
GSK announces “excellent” Q2 financial performance with growth across all…
GSK announces “excellent” Q2 financial performance with growth across all segments – Pharmaceuticals, Vaccines, Consumer Healthcare.
news
GSK to focus on vaccines and specialty medicines in next decade
In an investor update, GlaxoSmithKline (GSK) revealed its plan to…
In an investor update, GlaxoSmithKline (GSK) revealed its plan to promote growth and performance over next ten years.
news
GSK sets goals of net zero impact on environment by 2030
GSK will use 100 percent renewable electricity usage among other…
GSK will use 100 percent renewable electricity usage among other efforts in its plans to have a net zero impact on the climate by 2030.
article
Radical innovation occurs when pharma looks outside its own world
Pharma executives are committed to bringing drugs to market to…
Pharma executives are committed to bringing drugs to market to improve the lives of patients but is the industry too introspective to be truly innovative?
news
Sanofi and GSK to collaborate on COVID-19 vaccine development
Sanofi will provide its S protein antigen and GSK will…
Sanofi will provide its S protein antigen and GSK will contribute its adjuvant technology in a partnership to develop a COVID-19 vaccine.
article
Dr Penny Heaton, Bill & Melinda Gates MRI: ‘Lift while you climb’
As part of EPR’s Women in Pharma series, Dr Penny…
As part of EPR’s Women in Pharma series, Dr Penny Heaton, Chief Executive Officer, Bill & Melinda Gates Medical Research Institute, talks to Science Editor Dr Zara Kassam about the need to disrupt global health product development by applying cutting-edge science and technology to combat age-old diseases in the world’s…
